ReviewSkin health and disease2026
Recurrence of keratinocyte cancers after superficial radiation therapy.
Review in Skin health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Superficial radiation therapy (SRT) is a noninvasive treatment that uses low-energy X rays (50-150 kV) to treat skin cancers. SRT is used by dermatologists due to its accessibility and safety profile. Higher-energy radiation therapies are typically used by radiation oncologists. This narrative review aimed to evaluate the long-term clearance rates of keratinocyte cancers (KCs) treated with SRT. A literature search of MEDLINE, PubMed and Embase was performed in May 2024 and identified 12 studies that used SRT to treat KCs. The 12 studies included 6027 patients and reported a total of 9157 lesions treated with SRT. All studies were of a retrospective cohort design. No prospective cohort studies or randomized controlled trials (RCTs) were available for inclusion. Patients with KCs treated with SRT had a mean recurrence rate of 4.6% at the 3-year follow-up, with longer follow-up durations linked to higher recurrence rates (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.